Cargando…

Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth

BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velazquez-Torres, Guermarie, Fuentes-Mattei, Enrique, Choi, Hyun Ho, Yeung, Sai-Ching J, Meng, Xiangqi, Lee, Mong-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434590/ https://www.ncbi.nlm.nih.gov/pubmed/32843973 http://dx.doi.org/10.1093/gastro/goaa018

Ejemplares similares

Exenatide improves glucocorticoid-induced glucose intolerance in mice
por: Zhao, Ruiying, et al.
Publicado: (2011)

CSN6 drives carcinogenesis by positively regulating Myc stability
por: Chen, Jian, et al.
Publicado: (2014)

Impact of diabetes on promoting the growth of breast cancer
por: Chou, Ping‐Chieh, et al.
Publicado: (2021)

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
por: Feng, Yin-Hsun, et al.
Publicado: (2011)

Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage
por: Su, Chun-Hui, et al.
Publicado: (2010)

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
por: Gully, Christopher P, et al.
Publicado: (2010)

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
por: Phan, Liem Minh, et al.
Publicado: (2014)

The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming
por: Phan, Liem, et al.
Publicado: (2015)

Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer
por: Fuentes-Mattei, Enrique, et al.
Publicado: (2014)

Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells
por: Suzuki, Tatsunori, et al.
Publicado: (2021)

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
por: Kolb, Ryan, et al.
Publicado: (2016)

Mutant GNAS drives pancreatic tumorigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
por: Patra, Krushna C., et al.
Publicado: (2018)

The biological role of metabolic reprogramming in pancreatic cancer
por: Suzuki, Tatsunori, et al.
Publicado: (2020)

The role of metabolic reprogramming in pancreatic cancer chemoresistance
por: Liu, Chang, et al.
Publicado: (2023)

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer: The function of lipid metabolism reprogramming in pancreatic cancer
por: Guo, Duancheng, et al.
Publicado: (2023)

CSN6 deregulation impairs genome integrity in a COP1-dependent pathway
por: Choi, Hyun Ho, et al.
Publicado: (2015)

COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells
por: Nie, Ke, et al.
Publicado: (2020)

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
por: Somerville, Tim D.D., et al.
Publicado: (2018)

Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2022)

TBC1D8 Amplification Drives Tumorigenesis through Metabolism Reprogramming in Ovarian Cancer
por: Chen, Min, et al.
Publicado: (2019)

CDC5L drives FAH expression to promote metabolic reprogramming in melanoma
por: Gu, Zhichao, et al.
Publicado: (2017)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT
por: Onizuka, Hiromi, et al.
Publicado: (2021)

NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity
por: Meyer, Tom, et al.
Publicado: (2022)

TNFα-induced metabolic reprogramming drives an intrinsic anti-viral state
por: Ciesla, Jessica, et al.
Publicado: (2022)

Interferon signaling drives epithelial metabolic reprogramming to promote secondary bacterial infection
por: Carreno-Florez, Grace P., et al.
Publicado: (2023)

Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia
por: Liou, Geou-Yarh, et al.
Publicado: (2015)

Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming
por: Cai, Zhiwei, et al.
Publicado: (2023)

A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression
por: Velazquez-Torres, Guermarie, et al.
Publicado: (2018)

COP1 enhances ubiquitin-mediated degradation of p27(Kip1) to promote cancer cell growth
por: Choi, Hyun Ho, et al.
Publicado: (2015)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

Fructose drives mitochondrial metabolic reprogramming in podocytes via Hmgcs2-stimulated fatty acid degradation
por: Fang, Lei, et al.
Publicado: (2021)

Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations
por: Luo, Yongde, et al.
Publicado: (2013)

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
por: Shukla, Surendra K, et al.
Publicado: (2014)

PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
por: Murthy, Divya, et al.
Publicado: (2023)

REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors
por: Qiao, Shuxi, et al.
Publicado: (2020)

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming
por: Zuo, Sipeng, et al.
Publicado: (2022)

Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma
por: Li, Feiran, et al.
Publicado: (2023)

Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming
por: Su, Xinming, et al.
Publicado: (2023)

Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT
por: Meng, Qingcai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i8728nka60b08d1stdp6gflp7m